Literature DB >> 26809676

Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.

Dror Hibsh1, Kenneth H Buetow2, Gur Yaari3, Sol Efroni4.   

Abstract

The cancer genome is abnormal genome, and the ability to monitor its sequence had undergone a technological revolution. Yet prognosis and diagnosis remain an expert-based decision, with only limited abilities to provide machine-based decisions. We introduce a heterogeneity-based method for stratifying and visualizing whole-genome sequencing (WGS) reads. This method uses the heterogeneity within WGS reads to markedly reduce the dimensionality of next-generation sequencing data; it is available through the tool HiBS (Heterogeneity-Based Subclassification) that allows cancer sample classification. We validated HiBS using >200 WGS samples from nine different cancer types from The Cancer Genome Atlas (TCGA). With HiBS, we show progress with two WGS related issues: (i) differentiation between normal (NB) and tumor (TP) samples based solely on the information structure of their WGS data, and (ii) identification of specific regions of chromosomal amplification/deletion and their association with tumor stage. By comparing results to those obtained through available WGS analyses tools, we demonstrate some of the novelties obtained by the approach implemented in HiBS and also show nearly perfect normal/tumor classification, used to identify known and unknown chromosomal aberrations. Finally, the HiBS index has been associated with breast cancer tumor stage.
© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26809676      PMCID: PMC4872078          DOI: 10.1093/nar/gkw031

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line.

Authors:  Xiao-ying Zhang; Xun Qu; Cheng-qin Wang; Cheng-jun Zhou; Gui-xiang Liu; Feng-cai Wei; Shan-zhen Sun
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

Review 2.  [Biopsy: its history, current and future outlook].

Authors:  D D Zerbino
Journal:  Lik Sprava       Date:  1994 Mar-Apr

Review 3.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 4.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

5.  Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data.

Authors:  Valentina Boeva; Tatiana Popova; Kevin Bleakley; Pierre Chiche; Julie Cappo; Gudrun Schleiermacher; Isabelle Janoueix-Lerosey; Olivier Delattre; Emmanuel Barillot
Journal:  Bioinformatics       Date:  2011-12-06       Impact factor: 6.937

6.  Single-molecule analysis of genome rearrangements in cancer.

Authors:  Jessica C M Pole; Frank McCaughan; Scott Newman; Karen D Howarth; Paul H Dear; Paul A W Edwards
Journal:  Nucleic Acids Res       Date:  2011-04-27       Impact factor: 16.971

7.  Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

Authors:  Jens G Lohr; Viktor A Adalsteinsson; Kristian Cibulskis; Atish D Choudhury; Mara Rosenberg; Peter Cruz-Gordillo; Joshua M Francis; Cheng-Zhong Zhang; Alex K Shalek; Rahul Satija; John J Trombetta; Diana Lu; Naren Tallapragada; Narmin Tahirova; Sora Kim; Brendan Blumenstiel; Carrie Sougnez; Alarice Lowe; Bang Wong; Daniel Auclair; Eliezer M Van Allen; Mari Nakabayashi; Rosina T Lis; Gwo-Shu M Lee; Tiantian Li; Matthew S Chabot; Amy Ly; Mary-Ellen Taplin; Thomas E Clancy; Massimo Loda; Aviv Regev; Matthew Meyerson; William C Hahn; Philip W Kantoff; Todd R Golub; Gad Getz; Jesse S Boehm; J Christopher Love
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

8.  Gadd45a levels in human breast cancer are hormone receptor dependent.

Authors:  Jennifer S Tront; Alliric Willis; Yajue Huang; Barbara Hoffman; Dan A Liebermann
Journal:  J Transl Med       Date:  2013-05-24       Impact factor: 5.531

9.  CNV-seq, a new method to detect copy number variation using high-throughput sequencing.

Authors:  Chao Xie; Martti T Tammi
Journal:  BMC Bioinformatics       Date:  2009-03-06       Impact factor: 3.169

10.  ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.

Authors:  Rui Tian; Malay K Basu; Emidio Capriotti
Journal:  Bioinformatics       Date:  2014-09-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.